Work

Regimen Simplification to Atazanavir‐Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48‐Week Clinical and Virologic Outcomes

Year: 2020

Type: article

Abstract: Simplified maintenance therapy with ritonavir-boosted atazanavir (ATV/RTV) alone is attractive because of nucleoside reverse-transcriptase inhibitor (NRTI)–sparing benefits, low pill burden, once-daily dosage, and safety.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/jkhc-1w16

Authors: Mellors, John W., Swindells, Susan, Wiegand, Ann, Woodward, William, Thal, Gary, Palmer, Sarah, Maldarelli, Frank, DiRienzo, A. Gregory, Wilkin, Timothy J., Godfrey, Catherine, McKinnon, John E., Mollan, Katie, Bastow, Barbara, Fletcher, Courtney V., Margolis, David M., Coffin, John M.

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Pfizer, Gilead Sciences, University of Nebraska Medical Center, University of Pittsburgh, University of Cincinnati, ACT Government, Bavarian Nordic

OpenAlex ID: W4297963044

FWCI:

Cites:

Cited by:

Related to: 10